Published in Thyroid on February 01, 2009
Thyroid hormones are associated with cognitive function: moderation by sex, race, and depressive symptoms. J Clin Endocrinol Metab (2013) 0.93
Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes (2014) 0.92
Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci (2015) 0.79
Thyroid Function Variations Within the Reference Range Do Not Affect Quality of Life, Mood, or Cognitive Function in Community-Dwelling Older Men. Thyroid (2016) 0.75
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06
Thyroid status, disability and cognitive function, and survival in old age. JAMA (2004) 5.39
Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol (1991) 5.13
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid (2003) 4.48
Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1987) 3.58
Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc (1999) 3.05
A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med (2002) 3.04
Boston Naming Test: shortened versions for use in Alzheimer's disease. J Gerontol (1992) 2.23
Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med (2006) 1.47
Visual perception of line direction in patients with unilateral brain disease. Neurology (1975) 1.41
Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev (2002) 1.36
Neuropsychiatric aspects of hypothyroidism and treatment reversibility. . Minerva Endocrinol (2007) 1.35
Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab (2005) 1.32
Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry (1997) 1.22
Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig (1993) 1.16
Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology (2004) 1.12
Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol (2005) 1.10
Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab (2007) 1.07
fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain (2006) 1.07
Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr (2006) 1.03
Influences of thyroid stimulating hormone on cognitive functioning in very old age. J Gerontol B Psychol Sci Soc Sci (1998) 0.97
Thyroid hormones, learning and memory. Genes Brain Behav (2007) 0.96
Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2000) 0.92
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect (2005) 6.19
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes (2002) 6.05
Supply and demand analysis of the current and future US neurology workforce. Neurology (2013) 4.52
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid (2003) 4.48
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS (2005) 3.07
Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol (2012) 3.07
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ (2004) 2.70
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis (2012) 2.64
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med (2003) 2.63
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis (2007) 2.55
Ambient air pollution and the progression of atherosclerosis in adults. PLoS One (2010) 2.53
Childhood air pollutant exposure and carotid artery intima-media thickness in young adults. Circulation (2012) 2.51
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27
Postmenopausal hormone therapy in clinical perspective. Menopause (2007) 2.23
Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol (2008) 2.18
Hormone therapy and risk of Alzheimer disease: a critical time. JAMA (2002) 2.16
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy. J Am Geriatr Soc (2013) 2.11
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation (2002) 1.99
Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause (2006) 1.98
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol (2003) 1.93
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS (2007) 1.78
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause (2008) 1.74
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke (2008) 1.67
T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis (2011) 1.64
Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry (2005) 1.62
Unopposed estradiol therapy in postmenopausal women: results from two randomized trials. Obstet Gynecol (2007) 1.61
Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause (2005) 1.61
Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol (2014) 1.59
Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause (2011) 1.55
Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr (2004) 1.50
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. Atherosclerosis (2012) 1.50
LA Sprouts: a gardening, nutrition, and cooking intervention for Latino youth improves diet and reduces obesity. J Am Diet Assoc (2011) 1.49
Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke (2010) 1.44
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS (2013) 1.43
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis (2010) 1.42
Role of grandparenting in postmenopausal women's cognitive health: results from the Women's Healthy Aging Project. Menopause (2014) 1.41
A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia. Crit Care Med (2016) 1.39
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Preventing cognitive decline in usual aging. Arch Intern Med (2006) 1.38
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr (2012) 1.37
Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol (2002) 1.35
Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab (2004) 1.32
The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc (2006) 1.31
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30
Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol (2005) 1.26
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS (2009) 1.25
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol (2013) 1.25
Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid (2005) 1.23
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS (2013) 1.23
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2012) 1.22
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study. J Gerontol A Biol Sci Med Sci (2009) 1.21
Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimer's disease. Am J Alzheimers Dis Other Demen (2009) 1.20
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS (2014) 1.19
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis (2011) 1.18
Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS (2009) 1.18
Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke (2011) 1.18
Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis (2006) 1.17
Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol (2008) 1.15
A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke (2005) 1.13
Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2008) 1.13
A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause (2009) 1.12
Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses (2011) 1.12
Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. J Clin Endocrinol Metab (2004) 1.12
Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11
Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab (2004) 1.10
Environmental tobacco smoke and carotid arterial stiffness. Prev Med (2003) 1.10
The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic Biol Med (2003) 1.09
Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res (2010) 1.08
Effect of environmental perchlorate on thyroid function in pregnant women from Córdoba, Argentina, and Los Angeles, California. Endocr Pract (2011) 1.07
Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children. Atherosclerosis (2009) 1.07
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS (2015) 1.05